Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$6.56 - $10.95 $92,725 - $154,778
14,135 New
14,135 $97,000
Q1 2022

May 16, 2022

SELL
$9.74 - $17.92 $135,123 - $248,604
-13,873 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$12.27 - $18.49 $170,221 - $256,511
13,873 New
13,873 $201,000
Q3 2021

Nov 15, 2021

SELL
$13.38 - $18.8 $321,936 - $452,346
-24,061 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$17.08 - $29.6 $410,961 - $712,205
24,061 New
24,061 $422,000
Q2 2018

Aug 14, 2018

SELL
$16.46 - $20.33 $186,409 - $230,237
-11,325 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$17.08 - $25.64 $193,430 - $290,373
11,325 New
11,325 $198,000
Q4 2017

Feb 09, 2018

SELL
$21.47 - $27.8 $273,291 - $353,866
-12,729 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$23.02 - $28.8 $293,021 - $366,595
12,729
12,729 $328,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.